The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11510%2F17%3A10364907" target="_blank" >RIV/00216208:11510/17:10364907 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11240/17:10364907

Výsledek na webu

<a href="http://dx.doi.org/10.2147/CIA.S150826" target="_blank" >http://dx.doi.org/10.2147/CIA.S150826</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2147/CIA.S150826" target="_blank" >10.2147/CIA.S150826</a>

Jazyk výsledku

angličtina

Název v původním jazyce

The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)

Popis výsledku v původním jazyce

Muscle weakness and associated diseases are likely to place a considerable economic burden on government healthcare expenditure. Our aim for this study therefore, was to estimate the direct and indirect costs connected with muscle weakness in the Czech Republic. We applied a cost-of-illness approach, using data from the Survey of Health, Ageing and Retirement in Europe (SHARE). 689 participants aged 70 years and over and without any long-term illnesses were included in our study. A generalized linear model with the gamma distribution was carried out and odds ratio (OR) was calculated in order to explore the effect of muscle weakness on direct and indirect costs. For both genders, muscle weakness had a statistically significant impact on direct costs (OR = 2.11), but did not have a statistically significant impact on indirect costs (OR = 1.08) or on total cost (OR = 1.51). Muscle weakness had the greatest statistically significant impact on direct costs in females (OR = 2.75). In conclusion, our study has shown that muscle weakness may lead to increased direct costs and consequently place a burden on healthcare expenditure. Therefore, the results of this study could lead to greater interest in the prevention of muscle weakness amongst older people in the Czech Republic.

Název v anglickém jazyce

The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)

Popis výsledku anglicky

Muscle weakness and associated diseases are likely to place a considerable economic burden on government healthcare expenditure. Our aim for this study therefore, was to estimate the direct and indirect costs connected with muscle weakness in the Czech Republic. We applied a cost-of-illness approach, using data from the Survey of Health, Ageing and Retirement in Europe (SHARE). 689 participants aged 70 years and over and without any long-term illnesses were included in our study. A generalized linear model with the gamma distribution was carried out and odds ratio (OR) was calculated in order to explore the effect of muscle weakness on direct and indirect costs. For both genders, muscle weakness had a statistically significant impact on direct costs (OR = 2.11), but did not have a statistically significant impact on indirect costs (OR = 1.08) or on total cost (OR = 1.51). Muscle weakness had the greatest statistically significant impact on direct costs in females (OR = 2.75). In conclusion, our study has shown that muscle weakness may lead to increased direct costs and consequently place a burden on healthcare expenditure. Therefore, the results of this study could lead to greater interest in the prevention of muscle weakness amongst older people in the Czech Republic.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30306 - Sport and fitness sciences

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Clinical interventions in aging [online]

ISSN

1178-1998

e-ISSN

—

Svazek periodika

12

Číslo periodika v rámci svazku

prosinec

Stát vydavatele periodika

NZ - Nový Zéland

Počet stran výsledku

5

Strana od-do

2003-2007

Kód UT WoS článku

000416116400001

EID výsledku v databázi Scopus

2-s2.0-85038234026